Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bower, J. E.
Right arrow Articles by Fahey, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bower, J. E.
Right arrow Articles by Fahey, J. L.
Psychosomatic Medicine 64:604-611 (2002)
© 2002 American Psychosomatic Society

ORIGINAL ARTICLES

Fatigue and Proinflammatory Cytokine Activity in Breast Cancer Survivors

Julienne E. Bower, PhD, Patricia A. Ganz, MD, Najib Aziz, MD and John L. Fahey, MD

From the Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center (J.E.B., P.A.G.), the Schools of Medicine and Public Health (P.A.G.), the Center for Interdisciplinary Research in Immunology and Disease (N.A.), and the Department of Microbiology and Immunology (J.L.F.), the University of California, Los Angeles, California.

Address reprint requests to: Julienne E. Bower, PhD, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center at UCLA, 650 Charles Young Drive South, Room A2-125 CHS, Box 956900, Los Angeles, CA 90095-6900. Email: jbower{at}ucla.edu

OBJECTIVE: Fatigue is a common problem among cancer patients and survivors, yet the mechanisms underlying the occurrence and persistence of this symptom are not known. Activation of the immune system may evoke feelings of fatigue, which are mediated by proinflammatory cytokines. We examined whether fatigued breast cancer survivors would show elevations in proinflammatory cytokines and markers of cytokine activity compared with nonfatigued survivors. Differences in lymphocyte subsets, cortisol, and behavioral symptoms associated with proinflammatory cytokines were also assessed.

METHODS: Forty breast cancer survivors (20 fatigued, 20 nonfatigued) provided blood samples at visits scheduled to control for diurnal variability. Cytokines, soluble markers of cytokine activity, and cortisol were measured by immunoassay and lymphocyte subsets by flow cytometry. Participants also completed questionnaires measuring demographic, medical, and behavioral variables.

RESULTS: Fatigued breast cancer survivors had significantly higher serum levels of several markers associated with proinflammatory cytokine activity than nonfatigued survivors, including interleukin-1 receptor antagonist (IL-1ra), soluble tumor necrosis factor receptor type II (sTNF-RII), and neopterin. They were also more likely to report behavioral problems that co-occur with fatigue in the context of immune activation. Fatigued survivors had significantly lower serum levels of cortisol than the nonfatigued group as well as differences in two lymphocyte populations.

CONCLUSIONS: Fatigued breast cancer survivors showed elevations in serum markers associated with proinflammatory cytokine activity an average of 5 years after diagnosis. Results suggest mechanisms through which enduring immune activation may occur, including alterations in cortisol and in lymphocyte subsets.

Key Words: fatigue • breast cancer • proinflammatory cytokines • sickness behavior • cortisol

Abbreviations: ANCOVA = analysis of covariance; HPA = hypothalamic-pituitary-adrenal;; IL-1ß = interleukin-1 beta;; IL-1ra = interleukin-1 receptor antagonist; IL–6 = interleukin–6;; sTNF-RII = soluble tumor necrosis factor receptor II;; TNF-{alpha} = tumor necrosis factor alpha.




This article has been cited by other articles:


Home page
 Psychosom. Med.Home page
E. McAuley, S. M. White, L. Q. Rogers, R. W. Motl, and K. S. Courneya
Physical Activity and Fatigue in Breast Cancer and Multiple Sclerosis: Psychosocial Mechanisms
Psychosom Med, January 1, 2010; 72(1): 88 - 96.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
L. A. A. Gilliam, L. F. Ferreira, J. D. Bruton, J. S. Moylan, H. Westerblad, D. K. St. Clair, and M. B. Reid
Doxorubicin acts through tumor necrosis factor receptor subtype 1 to cause dysfunction of murine skeletal muscle
J Appl Physiol, December 1, 2009; 107(6): 1935 - 1942.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. E. Bower, P. A. Ganz, M. L. Tao, W. Hu, T. R. Belin, S. Sepah, S. Cole, and N. Aziz
Inflammatory Biomarkers and Fatigue during Radiation Therapy for Breast and Prostate Cancer
Clin. Cancer Res., September 1, 2009; 15(17): 5534 - 5540.
[Abstract] [Full Text] [PDF]

Home page
 Biol Res NursHome page
B. E. Aouizerat, M. Dodd, K. Lee, C. West, S. M. Paul, B. A. Cooper, W. Wara, P. Swift, L. B. Dunn, and C. Miaskowski
Preliminary Evidence of a Genetic Association Between Tumor Necrosis Factor Alpha and the Severity of Sleep Disturbance and Morning Fatigue
Biol Res Nurs, July 1, 2009; 11(1): 27 - 41.
[Abstract] [PDF]

Home page
 Psychosom. Med.Home page
M. Elovainio, A.-M. Aalto, M. Kivimaki, S. Pirkola, J. Sundvall, J. Lonnqvist, and A. Reunanen
Depression and C-Reactive Protein: Population-Based Health 2000 Study
Psychosom Med, May 1, 2009; 71(4): 423 - 430.
[Abstract] [Full Text] [PDF]

Home page
 Biol Res NursHome page
S. Al-Majid and D. P. Gray
A Biobehavioral Model for the Study of Exercise Interventions in Cancer-related Fatigue
Biol Res Nurs, April 1, 2009; 10(4): 381 - 391.
[Abstract] [PDF]

Home page
 Psychosom. Med.Home page
K. E. Freedland, E. J.C. de Geus, R. N. Golden, W. J. Kop, G. E. Miller, V. Vaccarino, B. Brumback, M. M. Llabre, V. J. White, and D. S. Sheps
What's in a Name? Psychosomatic Medicine and Biobehavioral Medicine
Psychosom Med, January 1, 2009; 71(1): 1 - 4.
[Full Text] [PDF]

Home page
 Psychosom. Med.Home page
P. Grossman, G. Deuring, S. N. Garland, T. S. Campbell, and L. E. Carlson
Patterns of Objective Physical Functioning and Perception of Mood and Fatigue in Posttreatment Breast Cancer Patients and Healthy Controls: An Ambulatory Psychophysiological Investigation
Psychosom Med, September 1, 2008; 70(7): 819 - 828.
[Abstract] [Full Text] [PDF]

Home page
 PsychosomaticsHome page
M. R. Levy
Cancer Fatigue: A Neurobiological Review for Psychiatrists
Psychosomatics, July 1, 2008; 49(4): 283 - 291.
[Abstract] [Full Text] [PDF]

Home page
 J Oncol PractHome page
S. C. Higgins, G. H. Montgomery, G. Raptis, and D. H. Bovbjerg
Effect of Pretreatment Distress on Daily Fatigue After Chemotherapy for Breast Cancer
J. Oncol. Pract, March 1, 2008; 4(2): 59 - 63.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. H. Miller, S. Ancoli-Israel, J. E. Bower, L. Capuron, and M. R. Irwin
Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer
J. Clin. Oncol., February 20, 2008; 26(6): 971 - 982.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. E. Bower
Behavioral Symptoms in Patients With Breast Cancer and Survivors
J. Clin. Oncol., February 10, 2008; 26(5): 768 - 777.
[Abstract] [Full Text] [PDF]

Home page
 FocusHome page
A. H. Miller and C. L. Raison
Immune System Contributions to the Pathophysiology of Depression
Focus, January 1, 2008; 6(1): 36 - 45.
[Abstract] [Full Text] [PDF]

Home page
 Palliat MedHome page
L. Radbruch, F. Strasser, F. Elsner, J. F. Goncalves, J. Loge, S. Kaasa, F. Nauck, P. Stone, and the Research Steering Committee of the European As
Fatigue in palliative care patients -- an EAPC approach
Palliative Medicine, January 1, 2008; 22(1): 13 - 32.
[Abstract] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
K. H. Schmitz, A. R. Cappola, C. T. Stricker, C. Sweeney, and S. A. Norman
The Intersection of Cancer and Aging: Establishing the Need for Breast Cancer Rehabilitation
Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 866 - 872.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
J. L. Ryan, J. K. Carroll, E. P. Ryan, K. M. Mustian, K. Fiscella, and G. R. Morrow
Mechanisms of Cancer-Related Fatigue
Oncologist, May 1, 2007; 12(suppl_1): 22 - 34.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
J. A. Roscoe, M. E. Kaufman, S. E. Matteson-Rusby, O. G. Palesh, J. L. Ryan, S. Kohli, M. L. Perlis, and G. R. Morrow
Cancer-Related Fatigue and Sleep Disorders
Oncologist, May 1, 2007; 12(suppl_1): 35 - 42.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. K. Adam, L. C. Hawkley, B. M. Kudielka, and J. T. Cacioppo
Day-to-day dynamics of experience-cortisol associations in a population-based sample of older adults
PNAS, November 7, 2006; 103(45): 17058 - 17063.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. F.M. Gielissen, S. Verhagen, F. Witjes, and G. Bleijenberg
Effects of Cognitive Behavior Therapy in Severely Fatigued Disease-Free Cancer Patients Compared With Patients Waiting for Cognitive Behavior Therapy: A Randomized Controlled Trial
J. Clin. Oncol., October 20, 2006; 24(30): 4882 - 4887.
[Abstract] [Full Text] [PDF]

Home page
 Biol Res NursHome page
L. J. Wood, L. M. Nail, N. A. Perrin, C. R. Elsea, A. Fischer, and B. J. Druker
The Cancer Chemotherapy Drug Etoposide (VP-16) Induces Proinflammatory Cytokine Production and Sickness Behavior-like Symptoms in a Mouse Model of Cancer Chemotherapy-Related Symptoms.
Biol Res Nurs, October 1, 2006; 8(2): 157 - 169.
[Abstract] [PDF]

Home page
 Psychosom. Med.Home page
J. Giese-Davis, F. H. Wilhelm, A. Conrad, H. C. Abercrombie, S. Sephton, M. Yutsis, E. Neri, C. B. Taylor, H. C. Kraemer, and D. Spiegel
Depression and stress reactivity in metastatic breast cancer.
Psychosom Med, September 1, 2006; 68(5): 675 - 683.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
N. Tellez, M. Comabella, E v. Julia, J. Rio, M a. Tintore, L. Brieva, C. Nos, and X. Montalban
Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone
Multiple Sclerosis, August 1, 2006; 12(4): 487 - 494.
[Abstract] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Collado-Hidalgo, J. E. Bower, P. A. Ganz, S. W. Cole, and M. R. Irwin
Inflammatory Biomarkers for Persistent Fatigue in Breast Cancer Survivors.
Clin. Cancer Res., May 1, 2006; 12(9): 2759 - 2766.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. P. Lee, M. J.A. de Jonge, A. E. O'Donnell, K. L. Schothorst, J. Hanwell, J. B. Chick, R. A. Brooimans, L. M. Adams, D. W. Drolet, J. S. de Bono, et al.
A Phase I Study of a New Nucleoside Analogue, OSI-7836, Using Two Administration Schedules in Patients with Advanced Solid Malignancies.
Clin. Cancer Res., May 1, 2006; 12(9): 2841 - 2848.
[Abstract] [Full Text] [PDF]

Home page
 International Journal of ToxicologyHome page
D. B. Colagiovanni, D. W. Drolet, L. Dihel, D. J. Meyer, K. Hart, and J. Wolf
Safety Assessment of 4'-Thio-{beta}-D-Arabinofuranosylcytosine in the Beagle Dog Suggests a Drug-Induced Centrally Mediated Effect on the Hypothalamic-Pituitary-Adrenal Axis
International Journal of Toxicology, March 1, 2006; 25(2): 119 - 126.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. E. Bower
Prevalence and Causes of Fatigue After Cancer Treatment: The Next Generation of Research
J. Clin. Oncol., November 20, 2005; 23(33): 8280 - 8282.
[Full Text] [PDF]

Home page
 JCOHome page
J. Savard, S. Simard, H. Ivers, and C. M. Morin
Randomized Study on the Efficacy of Cognitive-Behavioral Therapy for Insomnia Secondary to Breast Cancer, Part II: Immunologic Effects
J. Clin. Oncol., September 1, 2005; 23(25): 6097 - 6106.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
A. Shafqat, L. H. Einhorn, N. Hanna, G. W. Sledge, A. Hanna, B. E. Juliar, P. Monahan, and S. Bhatia
Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment{dagger}
Ann. Onc., September 1, 2005; 16(9): 1545 - 1550.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
J. E. Bower, P. A. Ganz, and N. Aziz
Altered Cortisol Response to Psychologic Stress in Breast Cancer Survivors With Persistent Fatigue
Psychosom Med, March 1, 2005; 67(2): 277 - 280.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
A Hartkamp, R Geenen, M Bijl, A A Kruize, G L R Godaert, and R H W M Derksen
Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjogren's syndrome
Ann Rheum Dis, October 1, 2004; 63(10): 1335 - 1337.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
F. Dimeo, A. Schmittel, T. Fietz, S. Schwartz, P. Kohler, D. Boning, and E. Thiel
Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment
Ann. Onc., August 1, 2004; 15(8): 1237 - 1242.
[Abstract] [Full Text] [PDF]

Home page
 J Natl Cancer Inst MonogrHome page
L. M. Nail
My Get Up and Go Got Up and Went: Fatigue in People With Cancer
J Natl Cancer Inst Monographs, July 1, 2004; 2004(32): 72 - 75.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
P. Flachenecker, I. Bihler, F Weber, M Gottschalk, K. V Toyka, and P. Rieckmann
Cytokine mRNA expression in patients with multiple sclerosis and fatigue
Multiple Sclerosis, April 1, 2004; 10(2): 165 - 169.
[Abstract] [PDF]

Home page
 JCOHome page
P. A. Ganz, C. M. Moinpour, D. K. Pauler, A. B. Kornblith, E. R. Gaynor, S. P. Balcerzak, G. S. Gatti, H. P. Erba, S. McCoy, O. W. Press, et al.
Health Status and Quality of Life in Patients With Early-Stage Hodgkin's Disease Treated on Southwest Oncology Group Study 9133
J. Clin. Oncol., September 15, 2003; 21(18): 3512 - 3519.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
J. E. Bower, P. A. Ganz, N. Aziz, J. L. Fahey, and S. W. Cole
T-Cell Homeostasis in Breast Cancer Survivors With Persistent Fatigue
J Natl Cancer Inst, August 6, 2003; 95(15): 1165 - 1168.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. D. Fossa, A. A. Dahl, and J. H. Loge
Fatigue, Anxiety, and Depression in Long-Term Survivors of Testicular Cancer
J. Clin. Oncol., April 1, 2003; 21(7): 1249 - 1254.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Psychosomatic Society